Sage Therapeutics, Inc.(NasdaqGM:SAGE) dropped from Russell 1000 Dynamic Index
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.47 USD | -3.93% | -6.10% | -42.46% |
04-25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
04-25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.46% | 781M | |
+3.41% | 106B | |
+7.02% | 23.47B | |
-14.77% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-9.26% | 16.78B | |
+5.25% | 14.41B | |
+37.33% | 12.86B | |
+329.69% | 8.78B |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- Sage Therapeutics, Inc.(NasdaqGM: SAGE) dropped from Russell 1000 Dynamic Index